Columbus-based Clarametyx Biosciences secures $33M in series A round funding. The proceeds from the round will enable the company to accelerate efforts across its...
NYC-based Medallion secures $13.7M in Series A round funding. Along with technology investors like Coinbase Ventures, Infinite Capital, J17, The Chernin Group, Third Prime,...
OnCusp Therapeutics, Inc., a biopharmaceutical company dedicated to transforming cutting-edge preclinical innovation into clinically validated treatments for cancer patients worldwide, today announced an oversubscribed $100 million Series A financing round.
Human Immunology Biosciences (HI-Bio™), a clinical-stage biotechnology company developing targeted therapies for patients with severe immune-mediated diseases (IMDs), announced the closing of a $95 million Series B financing led by new investor Alpha Wave Global. Viking Global Investors and Arkin Bio Capital participated in the financing, as well as existing investors Jeito Capital and ARCH Venture Partners.
To support rapid consumer adoption and expansion plans, Perplexity has raised $73.6 million in Series B funding from trusted VC firms and prominent tech visionaries. IVP led the round with continued support from Perplexity's Seed and Series A investors NEA, Elad Gil, Nat Friedman, and Databricks, as well as new investors NVIDIA, Jeff Bezos (through Bezos Expeditions Fund), Tobi Lutke, Bessemer Venture Partners, Naval Ravikant, Balaji Srinivasan, Guillermo Rauch, Austen Allred, Factorial Funds, and Kindred Ventures, among others.
Arbital Health, a technology startup focused on accelerating the healthcare industry's transition to value-based care, announced the acquisition of Santa Barbara Actuaries, Inc. (SBA), and $10 million in Series A financing led by digital healthcare investor Transformation Capital.
Nalu Medical Inc. (Nalu), a private company focused on innovative, minimally invasive, and non-opioid solutions for chronic neuropathic pain, announced today the closing of a $65 million equity financing. The round was led by a new investor, Novo Holdings (Novo).
CA-based Radionetics Oncology secures $52.5M in series A round funding. The round was led by Frazier Life Sciences, 5AM Ventures, and new investor, DCVC...
NJ-based BioCentriq secures $29.2M in series A round funding. In terms of BioCentriq's goal of translating, refining, and scaling processes for GMP manufacture in...
Oakberry, a Brazilian company, secures $67 million in a series C round funding. The Brazilian investment bank BTG Pactual (BPAC11) led the round.
The funds will...
